drugset / Trial / NCT01325337

Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia

NCT01325337

Phase 2 Completed 307 enrolled Allergan
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will evaluate the safety and efficacy of 3 doses of bimatoprost solution compared with vehicle and over-the-counter (OTC) minoxidil 5% solution in men with androgenic alopecia. All treatments will be provided in a double-blinded fashion except for minoxidil 5% solution which will be provided open-label.

Timeline

Start
2011-06
Primary completion
2012-08
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimatoprost Other / unclassified 1 ml Topical
Comparator Minoxidil Small molecule 1 ml Topical
Comparator Minoxidil Small molecule 5 % Topical